📣 VC round data is live. Check it out!

Jinhai Medical Technology Valuation Multiples

Discover revenue and EBITDA valuation multiples for Jinhai Medical Technology and similar public comparables like Persol Holdings, Korn Ferry, Robert Half, Adecco Group and more.

Jinhai Medical Technology Overview

About Jinhai Medical Technology

Jinhai Medical Technology Ltd is an investment holding company. Along with its subsidiaries, it is principally engaged in providing medical equipment in China and manpower outsourcing and ancillary services to building and construction contractors in Singapore. The group also provides IT services, construction ancillary services (which comprise warehousing, cleaning, and building maintenance works), and dormitory services in Singapore. It generates maximum revenue from the sale of minimally invasive surgery solutions, medical products, and related services in the People's Republic of China.


Founded

2017

HQ

China

Employees

488

Financials (FY)

Revenue: $36M
EBITDA: ($9M)

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Jinhai Medical Technology Financials

Jinhai Medical Technology reported last fiscal year revenue of $36M and negative EBITDA of ($9M).

In the same fiscal year, Jinhai Medical Technology generated $6M in gross profit, ($9M) in EBITDA losses, and had net loss of ($13M).


Jinhai Medical Technology P&L

In the most recent fiscal year, Jinhai Medical Technology reported revenue of $36M and EBITDA of ($9M).

Jinhai Medical Technology is unprofitable as of last fiscal year, with gross margin of 16%, EBITDA margin of (26%), and net margin of (37%).

See analyst estimates for Jinhai Medical Technology
Last FY202320242025202620272028
Revenue$36M$36M$39M$36M
Gross Profit$6M$9M$9M$6M
Gross Margin16%26%23%16%
EBITDA($9M)$869K($10M)($9M)
EBITDA Margin(26%)2%(25%)(26%)
EBIT Margin(39%)(10%)(40%)(39%)
Net Profit($13M)($2M)($14M)($13M)
Net Margin(37%)(7%)(36%)(37%)

Financial data powered by Morningstar, Inc.

Jinhai Medical Technology Stock Performance

Jinhai Medical Technology has current market cap of $3B, and enterprise value of $3B.

Market Cap Evolution


Jinhai Medical Technology's stock price is $0.60.

Jinhai Medical Technology share price increased by 4.7% in the last 30 days, and by 250.8% in the last year.

See more trading valuation data for Jinhai Medical Technology
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$3B4.7%4.7%134.9%250.8%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Jinhai Medical Technology Valuation Multiples

Jinhai Medical Technology trades at 86.8x EV/Revenue multiple, and (338.5x) EV/EBITDA.

See NTM and 2027E valuation multiples for Jinhai Medical Technology

Jinhai Medical Technology Financial Valuation Multiples

As of May 5, 2026, Jinhai Medical Technology has market cap of $3B and EV of $3B.

Jinhai Medical Technology has a P/E ratio of (236.5x).

Last FY202320242025202620272028
EV/Revenue86.8x88.0x80.0x86.8x
EV/EBITDAn/mn/mn/mn/m
EV/EBIT(224.6x)n/m(200.7x)(224.6x)
EV/Gross Profitn/mn/mn/mn/m
P/E(236.5x)n/m(224.8x)(236.5x)
EV/FCFn/mn/mn/mn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Jinhai Medical Technology Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Jinhai Medical Technology Margins & Growth Rates

In the most recent fiscal year, Jinhai Medical Technology reported gross margin of 16%, EBITDA margin of (26%), and net margin of (37%).

See estimated margins and future growth rates for Jinhai Medical Technology

Jinhai Medical Technology Margins

Last FY20242025202720282029
Gross Margin16%23%16%
EBITDA Margin(26%)(25%)(26%)
EBIT Margin(39%)(40%)(39%)
Net Margin(37%)(36%)(37%)
FCF Margin(12%)(8%)(12%)

Jinhai Medical Technology Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth10%(8%)
Gross Profit Growth(5%)(37%)
EBITDA Growth(1224%)(5%)
EBIT Growth354%(11%)
Net Profit Growth472%(5%)
FCF Growth36%33%

Data powered by FactSet, Inc. and Morningstar, Inc.

Jinhai Medical Technology Operational KPIs

Jinhai Medical Technology's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Jinhai Medical Technology
Last FY202320242025202620272028
Revenue per Employee$0.1M
Opex per Employee$0.0M
S&M Expenses to Revenue1%0%0%1%
G&A Expenses to Revenue53%35%64%53%
Opex to Revenue54%36%63%54%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Jinhai Medical Technology Competitors

Jinhai Medical Technology competitors include Persol Holdings, Korn Ferry, Robert Half, Adecco Group, First Advantage, Trinet Group, Meitec Group Holdings, ManpowerGroup, FESCO Group and Randstad.

Most Jinhai Medical Technology public comparables operate across Recruitment & Staffing.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Persol Holdings0.3x0.3x5.7x5.5x
Korn Ferry1.1x1.1x6.8x6.1x
Robert Half0.5x0.5x16.9x10.7x
Adecco Group0.3x0.3x7.1x6.9x
First Advantage2.6x2.5x10.6x8.9x
Trinet Group0.5x0.5x7.5x6.2x
Meitec Group Holdings1.4x1.4x9.4x9.4x
ManpowerGroup0.2x0.1x9.8x6.9x

This data is available for Pro users. Sign up to see all Jinhai Medical Technology competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Jinhai Medical Technology

When was Jinhai Medical Technology founded?Jinhai Medical Technology was founded in 2017.
Where is Jinhai Medical Technology headquartered?Jinhai Medical Technology is headquartered in China.
How many employees does Jinhai Medical Technology have?As of today, Jinhai Medical Technology has over 488 employees.
Who is the CEO of Jinhai Medical Technology?Jinhai Medical Technology's CEO is Zhenfei Wang.
Is Jinhai Medical Technology publicly listed?Yes, Jinhai Medical Technology is a public company listed on HKEX.
What is the stock symbol of Jinhai Medical Technology?Jinhai Medical Technology trades under 02225 ticker.
When did Jinhai Medical Technology go public?Jinhai Medical Technology went public in 2017.
Who are competitors of Jinhai Medical Technology?Jinhai Medical Technology main competitors include Persol Holdings, Korn Ferry, Robert Half, Adecco Group, First Advantage, Trinet Group, Meitec Group Holdings, ManpowerGroup, FESCO Group, Randstad.
What is the current market cap of Jinhai Medical Technology?Jinhai Medical Technology's current market cap is $3B.
What is the current revenue of Jinhai Medical Technology?Jinhai Medical Technology's last fiscal year revenue is $36M.
What is the current EV/Revenue multiple of Jinhai Medical Technology?Current revenue multiple of Jinhai Medical Technology is 86.8x.
Is Jinhai Medical Technology profitable?No, Jinhai Medical Technology is not profitable.
How many companies Jinhai Medical Technology has acquired to date?Jinhai Medical Technology hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Jinhai Medical Technology has invested to date?Jinhai Medical Technology hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Jinhai Medical Technology

Lists including Jinhai Medical Technology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial